Sally Ditzler

1.1k total citations
16 papers, 561 citations indexed

About

Sally Ditzler is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Sally Ditzler has authored 16 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Sally Ditzler's work include Hedgehog Signaling Pathway Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). Sally Ditzler is often cited by papers focused on Hedgehog Signaling Pathway Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). Sally Ditzler collaborates with scholars based in United States, South Africa and Australia. Sally Ditzler's co-authors include James M. Olson, Sue E. Knoblaugh, Barbara Pullar, Stacey Hansen, Beryl A. Hatton, Elisabeth H. Villavicencio, Joel I. Pritchard, Donghoon Lee, Donghoon Lee and Charles G. Eberhart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Sally Ditzler

16 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Ditzler United States 9 393 157 122 78 75 16 561
Shawon Debnath United States 8 369 0.9× 183 1.2× 113 0.9× 42 0.5× 76 1.0× 11 679
Pierre Moretti Germany 10 210 0.5× 301 1.9× 91 0.7× 97 1.2× 48 0.6× 26 551
Julia Bar Poland 13 207 0.5× 59 0.4× 135 1.1× 57 0.7× 93 1.2× 46 524
Tero Satomaa Finland 15 646 1.6× 238 1.5× 154 1.3× 52 0.7× 70 0.9× 27 957
Quanhai Li China 16 281 0.7× 105 0.7× 182 1.5× 36 0.5× 30 0.4× 33 662
Nagore G. Olaciregui Spain 9 471 1.2× 305 1.9× 93 0.8× 56 0.7× 59 0.8× 21 745
Changchen Hu China 13 264 0.7× 126 0.8× 84 0.7× 29 0.4× 54 0.7× 26 513
Sheng‐Hua Chu China 15 316 0.8× 67 0.4× 84 0.7× 48 0.6× 59 0.8× 29 508
Christine Günther Germany 9 189 0.5× 136 0.9× 147 1.2× 38 0.5× 33 0.4× 20 451
Guangli Suo China 14 333 0.8× 59 0.4× 73 0.6× 45 0.6× 101 1.3× 23 582

Countries citing papers authored by Sally Ditzler

Since Specialization
Citations

This map shows the geographic impact of Sally Ditzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Ditzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Ditzler more than expected).

Fields of papers citing papers by Sally Ditzler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Ditzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Ditzler. The network helps show where Sally Ditzler may publish in the future.

Co-authorship network of co-authors of Sally Ditzler

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Ditzler. A scholar is included among the top collaborators of Sally Ditzler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Ditzler. Sally Ditzler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hatton, Beryl A., Marc Grenley, Sally Ditzler, et al.. (2022). Abstract 620: Intratumoral microdosing via the CIVO® Platform reveals anti-tumor immune responses induced by the STING Agonist TAK-676 alone and in combination with chemotherapies. Cancer Research. 82(12_Supplement). 620–620. 1 indexed citations
2.
Hatton, Beryl A., Marc Grenley, James Garnsey, et al.. (2019). Abstract 4136: Direct intratumoral microdosing via the CIVO® platform reveals anti-tumor immune responses induced by the SUMO inhibitor TAK-981. Cancer Research. 79(13_Supplement). 4136–4136. 1 indexed citations
3.
Dey, Joyoti, Thomas L. Deckwerth, William Kerwin, et al.. (2017). Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition. Scientific Reports. 7(1). 72 indexed citations
4.
Dey, Joyoti, William Kerwin, Marc Grenley, et al.. (2016). A Platform for Rapid, Quantitative Assessment of Multiple Drug Combinations Simultaneously in Solid Tumors In Vivo. PLoS ONE. 11(6). e0158617–e0158617. 6 indexed citations
5.
Frazier, Jason P., et al.. (2016). Establishment and characterization of a canine soft tissue sarcoma patient‐derived xenograft model. Veterinary and Comparative Oncology. 15(3). 754–763. 2 indexed citations
6.
Dey, Joyoti, Sally Ditzler, Matthew C. Biery, et al.. (2016). Abstract 2835: Voruciclib, a clinical stage oral CDK inhibitor, sensitizes triple negative breast cancer xenografts to proteasome inhibition. Cancer Research. 76(14_Supplement). 2835–2835. 2 indexed citations
7.
Girard, Emily J., Sally Ditzler, Donghoon Lee, et al.. (2014). Efficacy of cabazitaxel in mouse models of pediatric brain tumors. Neuro-Oncology. 17(1). 107–115. 27 indexed citations
8.
Dey, Joyoti, Sally Ditzler, Sue E. Knoblaugh, et al.. (2012). A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model. Molecular and Cellular Biology. 32(20). 4104–4115. 35 indexed citations
9.
Hatton, Beryl A., Elisabeth H. Villavicencio, Paritosh C. Khanna, et al.. (2012). Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model. Proceedings of the National Academy of Sciences. 109(20). 7859–7864. 103 indexed citations
10.
Veiseh, Omid, Narayan Bhattarai, Conroy Sun, et al.. (2010). Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method. PLoS ONE. 5(4). 7 indexed citations
11.
Hatton, Beryl A., Elisabeth H. Villavicencio, Joel I. Pritchard, et al.. (2010). Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene. 29(26). 3865–3872. 16 indexed citations
12.
Veiseh, Omid, Narayan Bhattarai, Conroy Sun, et al.. (2010). Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method. PLoS ONE. 5(3). e9536–e9536. 87 indexed citations
13.
Veiseh, Omid, Narayan Bhattarai, Conroy Sun, et al.. (2010). Correction: Rapid Pharmacokinetic and Biodistribution Studies Using Chlorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method. PLoS ONE. 5(3). 8 indexed citations
14.
Hatton, Beryl A., Elisabeth H. Villavicencio, Karen D. Tsuchiya, et al.. (2008). The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread. Cancer Research. 68(6). 1768–1776. 137 indexed citations
15.
Ditzler, Sally, et al.. (2007). Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). Journal of Neuro-Oncology. 87(2). 133–141. 50 indexed citations
16.
Ditzler, Sally, et al.. (2003). A Rapid Neurobehavioral Assessment Reveals that FK506 Delays Symptom Onset in R6/2 Huntington's Disease Mice. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shawon Debnath Breakdown of academic impact, for papers by Pierre Moretti Breakdown of academic impact, for papers by Julia Bar Breakdown of academic impact, for papers by Tero Satomaa Breakdown of academic impact, for papers by Quanhai Li Breakdown of academic impact, for papers by Nagore G. Olaciregui Breakdown of academic impact, for papers by Changchen Hu Breakdown of academic impact, for papers by Sheng‐Hua Chu Breakdown of academic impact, for papers by Christine Günther Breakdown of academic impact, for papers by Guangli Suo
Rankless by CCL
2026